|
Accession number;05A0468415
|
| Title;NPPV Treatment for the Patients with Sleep Apnea Syndrome |
| Author;
MIYAZAWA NAOKI
(Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center, JPN)
NAKAMURA MARI
(Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center, JPN)
WATANUKI YUJI
(Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center, JPN)
OGURA TAKASHI
(Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center, JPN)
TAKAHASHI HIROSHI
(Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center, JPN)
|
Journal Title;Japanese Journal of Intensive Care Medicine
|
Journal Code:Z0581B
|
ISSN:0389-1194
|
|
VOL.29;NO.3;PAGE.201-206(2005)
|
| Figure&Table&Reference;FIG.2, TBL.1, REF.15 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Sleep apnea syndrome (SAS) is divided into two criteria: obstructive SAS (OSAS) that is mainly associated with obesity and central SAS (CSAS) from chronic heart failure or central nerve disorder. Obesity hypoventilation syndrome (OHS) is thought as the most severe type of OSAS. First choice therapy of OSAS and CSAS is continuous positive airway pressure (CPAP) treatment. However, noninvasive positive pressure ventilation (NPPV) is indicated for SAS patients who cannot tolerate CPAP due to discomfort exhaling against positive pressure. NPPV is also useful for patients with OHS and Cheyne-Stokes respiration that is typical symptom of CSAS, because the difference pressure of IPAP-EPAP works as pressure support ventilation. Hypoventilation causes sleep disorder in patients with restrictive thoracic diseases (such as post-tuberculosis sequelae or kyphoscoliosis) and chronic obstructive pulmonary disease (COPD), especially during rapid eye movement (REM) sleep. NPPV is indicated for those patients with concomitant SAS and hypercapnea due to nocturnal hypoventilation. (author abst.) |
|
|
|
Related Articles;
|
